Bloomberg News

Zealand Pharma’s Lixisenatide Effective Mornings and Evenings

December 10, 2011

Dec. 8 (Bloomberg) -- Zealand Pharma A/S said a study has shown both morning and evening administration of its once-daily diabetes drug lixisenatide significantly cut blood sugar levels.

To contact the editor responsible for this story: Frances Schwartzkopff at fschwartzko1@bloomberg.net


Coke's Big Fat Problem
LIMITED-TIME OFFER SUBSCRIBE NOW

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

 
blog comments powered by Disqus